rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-11-26
|
pubmed:abstractText |
The melanoma differentiation-associated gene-7 (mda-7/IL24) is a unique member of the IL-10 family of cytokines, with ubiquitous tumor cell proapoptotic activity. Transduction of tumor or normal cells with the mda-7 gene results in secretion of glycosylated MDA-7 protein. Recent data indicate that secreted MDA-7 protein functions as a pro-Th1 cytokine and as a potent antiangiogenic molecule. MDA-7 protein binds two distinct type II cytokine heterodimeric receptor complexes, IL-20R1/IL-20R2 (type 1 IL-20R) and IL-22R1/IL-20R2 (type 2 IL-20R). In this study we analyzed the activity of glycosylated secreted MDA-7 against human melanoma cells. MDA-7 protein induces phosphorylation and nuclear translocation of STAT3 in melanoma cells via both type 1 and type 2 IL-20R. MDA-7 induces dose-dependent cell death in melanoma tumor cells. MDA-7 receptor engagement results in up-regulation of BAX and subsequent apoptosis induction; this effect is mediated by STAT3-independent signaling. Additional IL-10 family members (IL-10, -19, -20, and -22) also activate STAT3; however, these ligands do not activate death pathways in melanoma. In normal cells, MDA-7 can bind to its cognate receptors and induce phosphorylation of STAT3, without cytotoxic sequelae. This study defines a tumor-selective cytotoxic bystander role for secreted MDA-7 protein and identifies a novel receptor-mediated, STAT3-independent, and PKR-independent death pathway.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/eIF-2 Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-20 receptor,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-24
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1525-0016
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1085-95
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15564140-Active Transport, Cell Nucleus,
pubmed-meshheading:15564140-Adenoviridae,
pubmed-meshheading:15564140-Apoptosis,
pubmed-meshheading:15564140-Bystander Effect,
pubmed-meshheading:15564140-Cell Cycle,
pubmed-meshheading:15564140-Cell Line, Tumor,
pubmed-meshheading:15564140-DNA-Binding Proteins,
pubmed-meshheading:15564140-Genes, Tumor Suppressor,
pubmed-meshheading:15564140-Humans,
pubmed-meshheading:15564140-Interleukin-10,
pubmed-meshheading:15564140-Interleukins,
pubmed-meshheading:15564140-Melanoma,
pubmed-meshheading:15564140-Phosphorylation,
pubmed-meshheading:15564140-Receptors, Interleukin,
pubmed-meshheading:15564140-STAT3 Transcription Factor,
pubmed-meshheading:15564140-Trans-Activators,
pubmed-meshheading:15564140-eIF-2 Kinase
|
pubmed:year |
2004
|
pubmed:articleTitle |
Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
|
pubmed:affiliation |
Introgen Therapeutics, Inc., Houston, TX 77030, USA. s.chada@introgen.com
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|